The Translational Research Institute (TRI) delivers world-class facilities dedicated to creating a unique environment where discovery, innovation and translation thrives. With the 2025 opening of our translational biomedical manufacturing facility, TRI will become the largest end-to-end translational campus of its kind in Australia.

Based at the Princess Alexandra Hospital in Queensland’s dedicated life sciences precinct, TRI provides support and opportunities in research and development, clinical trials and manufacturing.

At TRI, we are transforming health by fostering collaborative research to fast-track translational outcomes for medical research.

We are the interface of science, medicine and industry. Through our connections to government and regulatory bodies, relationships with industry and the life sciences sector, we promote excellence in exceptional science, product development and clinical pathways.